Tonix Pharmaceuticals stock halted ahead of FDA approval news
LONDON - Barclays PLC (LON:BARC) has disclosed its holdings in Dalata Hotel Group PLC, in accordance with the Irish Takeover Panel Act of 1997, Takeover Rules, 2022. As of Monday, the financial institution reported a combined interest and short position representing 1.10% and 1.13% respectively in the hotel operator’s shares.
The disclosure, mandated under Rule 8.3 of the Takeover Code, comes as Dalata Hotel Group finds itself the subject of increased market attention. Barclays’ position includes direct ownership of 1,608,011 shares and short positions amounting to 768,069 shares. Additionally, the bank holds 716,151 shares through cash-settled derivatives and a corresponding short position via derivatives of 1,620,670 shares.
Barclays engaged in multiple transactions involving Dalata’s ordinary shares on the previous trading day, with purchases ranging from 14 to 16,186 shares at prices between 5.2900 and 5.3300 EUR. Concurrently, sales transactions were recorded for quantities varying from 31 to 6,365 shares, at similar price levels.
The bank also reported adjustments in its derivative positions, with swaps both increasing and decreasing short positions in quantities ranging from 1 to 7,975 shares, at prices close to the purchase and sale transactions.
No indemnity or option arrangements were reported, and there was no indication of agreements or understandings related to the voting rights of the relevant securities.
This disclosure is part of the regulatory requirements that provide transparency in the market, particularly during takeover situations where parties may have a significant interest in the involved companies. The information is based on a press release statement and is intended to inform investors of Barclays’ dealings in the securities of Dalata Hotel Group PLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.